optimal environmental conditions in life science facilities · pdf filegamp compliant hvac...

Optimal environmental conditions in life science facilities

Rudi Heymans

Seite 2 June 2009 © Siemens NV/SA 2009

Seite 3 June 2009 © Siemens NV/SA 2009

What are the reasons to think and talk about the environmental impact of the Life Science Industry?

Global warming?

Public image?

Share Value?

Company development?

Optimize Operational Costs and Improve Competitiveness?

It’s about all of these topics!

Seite 4 June 2009 © Siemens NV/SA 2009

What are the reasons to think and talk about the environmental impact of the Life Science Industry?

Global warming?

Public image?

Share Value?

Company development?

Optimize Operational Costs and Improve Competitiveness?

It’s about all of these topics!

Seite 5 June 2009 © Siemens NV/SA 2009

Distribution of Energy use in the Life Sciences – energy consumption

25%

10%65%

Plug loads andprocesses

Lighting

HVAC

Other

Source: Energy Efficiency Improvement and Cost Saving Opportunities for Pharmaceutical Industry. Ernest Orlando Lawrence Berlely National Laboratory, Sept 2005

Seite 6 June 2009 © Siemens NV/SA 2009

Distribution of Energy use in the Pharmacuetical Industry – building types

30%

10%

35%

15%

5%5%

R&D

Offices

Bulk Manufacturing

Formulation,Packaging & FillingWarehouses

Miscellaneous

Source: Energy Efficiency Improvement and Cost Saving Opportunities for Pharmaceutical Industry. Ernest Orlando Lawrence Berlely National Laboratory, Sept 2005

Seite 7 June 2009 © Siemens NV/SA 2009

What are the reasons to think and talk about the environmental impact of the Life Science Industry?

Global warming?

Public image?

Share Value?

Company development?

Optimize Operational Costs and Improve Competitiveness?

It’s about all of these topics!

Seite 8 June 2009 © Siemens NV/SA 2009

Pharmaceutical Companies Image

[source: Annabel Evans, Ipsos, April 11, 2007¨]

• In the US Pharmaceutical companies receive little recognition from the public for their social contributions and investments

• 60% of the interviewed individuals are the opinion that Pharma companies do not pay enough attention to their social an environmental responsibilities

Seite 9 June 2009 © Siemens NV/SA 2009

What are the reasons to think and talk about the environmental impact of the Life Science Industry?

Global warming?

Public image?

Share Value?

Company development?

Optimize Operational Costs and Improve Competitiveness?

It’s about all of these topics!

Seite 10 June 2009 © Siemens NV/SA 2009

DJSI Application for Pharma companies

ECONOMIC DIMENSION (37%)– Brand Management– Customer Relationship Management– Marketing Practices– Research and Development

ENVIRONMENTAL DIMENSION (18%)– Advanced Environmental Performance– Climate Strategy– Environmental Policy/ Management System

SOCIAL DIMENSION (45%)– Animal Testing– Bioethics– Occupational Health&Safety– Stakeholder Engagement– Standards for Suppliers– Strategy to Improve Access to Drugs

Seite 11 June 2009 © Siemens NV/SA 2009

What are the reasons to think and talk about the environmental impact of the Life Science Industry?

Global warming?

Public image?

Share Value?

Company development?

Optimize Operational Costs and Improve Competitiveness?

It’s about all of these topics!

Seite 12 June 2009 © Siemens NV/SA 2009

Systems to provide energy reducing solutions & compliant environment conditions

Compliant Total Building Solutions

Calibrated/certified Field Devices

GAMP compliant HVAC automation

Electronic Validation Tool

Vendor Audit Reports

Archiving and Reporting

Operation and Supervision

Validated Access Control

Compact MonitoringTechnology CMTLaboratory Solution

+

Seite 13 June 2009 © Siemens NV/SA 2009

Siemens Laboratory SolutionFlexible and fully integrated solution to control complex air flow and optimize your energy consumption

More Reliable

Dedicated energy consumptionreport per user

All information available to improve your maintenance

An overview of your system functionality

Seite 14 June 2009 © Siemens NV/SA 2009

All you need for validationWe follow the recommendation of the GAMP 5’s V-Model

Time to Marketrisk minimizingCost reducing

Traceability

Documentation management

Risk based approach

Pre tested, pre configured

URSFS

CMP

SATS

Verificationchecklist

FAT

SATFATS

DesignReview

TraditionalIQ/OQ

SDS

Seite 15 June 2009 © Siemens NV/SA 2009

What are the reasons to think and talk about the environmental impact of the Life Science Industry?

Global warming?

Public image?

Share Value?Share Value?

Company development? Company Development?

Optimize Operational Costs and Improve Competitiveness?Optimize operational cost andImprove competitiveness?

It’s about all of these topics!

Thank you for your attention

Rudi Heymans